Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 01, 2019
Aetion announced a new integrated solution focused on advancing the use of real-world evidence for small and mid-sized biopharmaceutical companies.
read more
Wednesday, August 07, 2019
Aevi has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human monoclonal antibody (mAb) that targets interleukin 18.
read more
Avacta Group plc announced a study that has shown the AffiDX antigen lateral flow test detects the Delta variant of the SARS-CoV-2 virus in clinical samples and, in this small study, outperformed two lateral flow antigen tests that are commercially ...
read more
The collaboration will utilize Affinivax’s proprietary vaccine platform, Multiple Antigen Presentation System (MAPS), to develop vaccines to prevent bacterial nosocomial infections, also referred to as health-care associated infections (HAIs).
read more
Wednesday, December 02, 2015
Affymetrix Inc. and Reveal Biosciences LLC, an advanced tissue technologies company, have announced a partnership agreement through which Reveal will use Affymetrix ViewRNA® ISH products for tissue samples to provide RNA in situ hybridization (ISH) ...
read more
On May 19-21 in Boston, clinical trial sponsors, CROs, sites and leaders from around the world will gather at the inaugural CenterWatch Forum on Optimizing Clinical Research Performance conference to discuss collaboration and innovation within a ...
read more
FDA issues final guidance for oversight of clinical investigations, recommends a quality risk-management approach to clinical trials
read more
More than half of all image-related clinical trial query stoppages result from preventable human errors, according to industry research. In response, AG Mednet announces its “Submission Quality & Compliance” module that delivers a new layer of ...
read more
Tuesday, September 06, 2016
AGC Asahi Glass, a manufacturer of glass, chemicals and high-tech materials, has acquired all of the shares of Biomeva GmbH (Biomeva) from Biomeva Holding GmbH.
read more
AGC Biologics and BioConnection have announced a new strategic partnership. The companies are partnering to provide end- to-end biopharmaceutical development and manufacturing capabilities for drug substance and drug product using the development and...
read more
Friday, December 16, 2022
AGC Biologics announced a collaboration with W.L. Gore & Associates that features Protein A affinity purification technology from Gore alongside the CDMO’s contract development and manufacturing services.
read more
Thursday, October 23, 2025
AGC Biologics has entered into an agreement with Rarity PBC to develop and manufacture RDP-101, a breakthrough gene therapy targeting Adenosine Deaminase Severe Combined Immunodeficiency Disorder (ADA-SCID), also known as “Bubble Baby Disease”.
read more
Robert Broeze will retire on March 5th, 2019 after a 35-year career in the biopharmaceutical industry.
read more
Monday, November 15, 2021
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced Jean-Baptiste Agnus has been appointed as the company’s Chief Business Officer (CBO). In this position, he is responsible for ...
read more
AGC Biologics announced the appointment of Kasper Møller to the role of Chief Technical Officer.
read more